Among this cohort, 24 (7.0%) participants were sputum smear microscopy (AFB) positive, with an estimated population prevalence of 4.6–10.3%. Sixty-three (18.4%) participants had either a positive ...

This phase III two-sided equivalence trial compares 4 and 6 months of TB treatment (2 months of daily treatment with INH, rifampicin, ethambutol and pyrazinamide followed by either 2 or 4 months of ...

A new clinical decision support system, "TBorNotTB," helps streamline airborne infection isolation decisions, reducing workload while maintaining TB detection accuracy. Study: TB or not TB?

We conducted a prospective clinic-based study of newly-diagnosed HIV-infected adults who presented for voluntary HIV counseling and testing from October 2010 to May 2011. Enrollment, specimen ...